GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,931.50
-8.50 (-0.44%)
Jul 31, 2026, 4:54 PM GMT
GSK plc Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 33,203 | 32,667 | 31,376 | 30,328 | 29,324 | 24,696 | |
Revenue Growth | 4.97% | 4.12% | 3.46% | 3.42% | 18.74% | 1.40% |
Cost of Revenue | 8,801 | 8,947 | 8,845 | 8,388 | 9,407 | 8,033 |
Gross Profit | 24,402 | 23,720 | 22,531 | 21,940 | 19,917 | 16,663 |
Selling, General & Admin | 9,105 | 9,013 | 10,847 | 9,156 | 8,179 | 6,784 |
Research & Development | 6,978 | 6,654 | 6,078 | 5,823 | 5,153 | 4,627 |
Other Operating Expenses | -1,367 | -1,394 | -584 | -1,442 | -737 | -382 |
Operating Expenses | 14,716 | 14,273 | 16,341 | 13,537 | 12,595 | 11,029 |
Operating Income | 9,686 | 9,447 | 6,190 | 8,403 | 7,322 | 5,634 |
Interest Expense | -661 | -658 | -615 | -710 | -819 | -762 |
Interest & Investment Income | 123 | 147 | 132 | 108 | 62 | 13 |
Earnings From Equity Investments | -4 | 1 | -3 | -5 | -2 | 33 |
Other Non Operating Income (Expenses) | -21 | -21 | -63 | -74 | -44 | -6 |
EBT Excluding Unusual Items | 9,123 | 8,916 | 5,641 | 7,722 | 6,519 | 4,912 |
Merger & Restructuring Charges | -123 | -109 | -354 | -383 | -323 | -424 |
Gain (Loss) on Sale of Investments | -24 | -24 | 57 | -121 | 256 | 1 |
Gain (Loss) on Sale of Assets | 106 | 106 | 246 | 61 | 215 | 552 |
Asset Writedown | -2,415 | -888 | -320 | -398 | -296 | -347 |
Legal Settlements | - | - | - | - | 922 | - |
Other Unusual Items | -763 | -600 | -1,793 | -817 | -1,665 | -1,095 |
Pretax Income | 5,904 | 7,401 | 3,477 | 6,064 | 5,628 | 3,599 |
Income Tax Expense | 641 | 1,112 | 526 | 756 | 707 | 83 |
Earnings From Continuing Operations | 5,263 | 6,289 | 2,951 | 5,308 | 4,921 | 3,516 |
Earnings From Discontinued Operations | - | - | - | - | 10,495 | 1,069 |
Net Income to Company | 5,263 | 6,289 | 2,951 | 5,308 | 15,416 | 4,585 |
Minority Interest in Earnings | -442 | -573 | -376 | -380 | -460 | -200 |
Net Income | 4,821 | 5,716 | 2,575 | 4,928 | 14,956 | 4,385 |
Net Income to Common | 4,821 | 5,716 | 2,575 | 4,928 | 14,956 | 4,385 |
Net Income Growth | 40.84% | 121.98% | -47.75% | -67.05% | 241.07% | -23.73% |
Shares Outstanding (Basic) | 4,022 | 4,051 | 4,077 | 4,052 | 4,026 | 4,003 |
Shares Outstanding (Diluted) | 4,089 | 4,117 | 4,142 | 4,111 | 4,084 | 4,052 |
Shares Change | -1.36% | -0.60% | 0.75% | 0.66% | 0.79% | 0.55% |
EPS (Basic) | 1.20 | 1.41 | 0.63 | 1.22 | 3.71 | 1.10 |
EPS (Diluted) | 1.18 | 1.39 | 0.62 | 1.20 | 3.66 | 1.08 |
EPS Growth | 42.63% | 123.15% | -48.12% | -67.26% | 238.48% | -24.16% |
Free Cash Flow | 6,898 | 6,393 | 5,155 | 5,454 | 6,260 | 7,002 |
Free Cash Flow Per Share | 1.69 | 1.55 | 1.25 | 1.33 | 1.53 | 1.73 |
Dividend Per Share | 0.680 | 0.660 | 0.610 | 0.580 | 0.613 | 1.000 |
Dividend Growth | 7.94% | 8.20% | 5.17% | -5.31% | -38.75% | 0% |
Gross Margin | 73.49% | 72.61% | 71.81% | 72.34% | 67.92% | 67.47% |
Operating Margin | 29.17% | 28.92% | 19.73% | 27.71% | 24.97% | 22.81% |
Profit Margin | 14.52% | 17.50% | 8.21% | 16.25% | 51.00% | 17.76% |
Free Cash Flow Margin | 20.77% | 19.57% | 16.43% | 17.98% | 21.35% | 28.35% |
EBITDA | 10,818 | 11,335 | 8,319 | 10,507 | 9,293 | 7,756 |
EBITDA Margin | 32.58% | 34.70% | 26.51% | 34.64% | 31.69% | 31.41% |
D&A For EBITDA | 1,132 | 1,888 | 2,129 | 2,104 | 1,971 | 2,122 |
EBIT | 9,686 | 9,447 | 6,190 | 8,403 | 7,322 | 5,634 |
EBIT Margin | 29.17% | 28.92% | 19.73% | 27.71% | 24.97% | 22.81% |
Effective Tax Rate | 10.86% | 15.02% | 15.13% | 12.47% | 12.56% | 2.31% |
Advertising Expenses | - | 738 | 851 | 835 | 735 | 433 |